Shahnawaz Ibrahim

Shahnawaz Ibrahim is an accomplished professional with extensive experience in pharmacovigilance and medical information, currently serving as the Head of Pharmacovigilance and Medical Information Operations at Lupin since June 2018. Prior to this role, Shahnawaz held the position of Head of Pharmaceutical Practice at a confidential organization and served as Senior Manager of Pharmacovigilance and Safety Writing at PharmaLex. Shahnawaz’s career began at Ranbaxy Laboratories Limited, where responsibilities included regional oversight of pharmacovigilance and medical affairs across multiple regions. Educational qualifications include a Master of Business Administration in International Marketing and a Master's in Pharmacy, complemented by various certifications in drug safety and pharmacovigilance from esteemed organizations such as the US FDA and Uppsala Monitoring Centre.